ArticleCommunications biology2018

Experimental severe malaria is resolved by targeting newly-identified monocyte subsets using immune-modifying particles combined with artesunate.

Paula Niewold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.